Emerging therapies for small cell lung cancer

Emerging therapies for small cell lung cancer

Abstract Currently, chemotherapy remains the standard treatment for first- and second-line management of small cell lung cancer (SCLC). Immunotherapy has made progress in the treatment of SCLC, and nivolumab, pembrolizumab, atezolizumab, and durvalumab have led to significant improvements in clinica...

Full description

Bibliographic Details
Main Authors: Sen Yang, Zhe Zhang, Qiming Wang
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Journal of Hematology & Oncology
Subjects:
Small cell lung cancer
Chemotherapy
Immunotherapy
Targeted therapy
Online Access:http://link.springer.com/article/10.1186/s13045-019-0736-3

Internet

http://link.springer.com/article/10.1186/s13045-019-0736-3

Similar Items